After mounting concern over reports of rare but serious blood clots in a small number of recipients of the Oxford/AstraZeneca vaccine, last week the UK’s Joint Committee on Vaccination and Immunisation (JCVI) recommended that healthy adults under 30 should have an alternative jab if they can. To find out what’s behind the change in advice, Nicola Davis speaks to Dr Sue Pavord about what this rare clotting syndrome is, and asks Prof Adam Finn about how the JCVI made its decision

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Eurovision song contest 2023: seven UK cities named as potential hosts

Birmingham, Glasgow, Leeds, Liverpool, Manchester, Newcastle and Sheffield all in running to…

Facebook down

Is Facebook down, Instagram down, is instagram down